EN | 简 |
Contact Us
EN | 简 |
Development Milestones

Our Journey

Development Milestones Key Milestones Honors and Certifications
<p>JW Therapeutics Founded</p>

JW Therapeutics Founded

2016

<p><strong>JW Therapeutics (HKEX: 2126)</strong><br>Listed on the Main Board of the Hong Kong Stock Exchange</p>

JW Therapeutics (HKEX: 2126)
Listed on the Main Board of the Hong Kong Stock Exchange

November 2020

<p>Carteyva® (Relmacabtagene Autoleucel Injection) Approved by the NMPA as China's first Class 1 CAR-T therapy</p>

Carteyva® (Relmacabtagene Autoleucel Injection) Approved by the NMPA as China's first Class 1 CAR-T therapy

September 2021

<p>Signed an <strong>sLVV technology licensing</strong> <strong>agreement</strong> with Juno Therapeutics, enabling technology out-licensing. Entered into a strategic collaboration expansion agreement with Regeneron.</p>

Signed an sLVV technology licensing agreement with Juno Therapeutics, enabling technology out-licensing. Entered into a strategic collaboration expansion agreement with Regeneron.

April–October 2025

<p><strong>Carteyva® </strong>approved by the <strong>Macau Special Administrative Region Health Bureau</strong> for marketing</p>

Carteyva® approved by the Macau Special Administrative Region Health Bureau for marketing

June 2025

<p><strong>Carteyva®</strong> included in the inaugural <strong>National Commercial Health Insurance Innovative Drug List</strong></p>

Carteyva® included in the inaugural National Commercial Health Insurance Innovative Drug List

June 2025

Driven by innovation and guided by patients, JW Therapeutics is committed to advancing the development and accessibility of CAR-T therapies.

<p>Innovation-Driven</p>

Innovation-Driven

Advancing Breakthroughs and Expanding Access to CAR-T Therapies

<p>Compliance First</p>

Compliance First

Upholding High Standards of Quality and Regulatory Compliance

<p>Global Collaboration</p>

Global Collaboration

Strengthening International Partnerships and Expanding Our Global Footprint

<p>Patient-Centric</p>

Patient-Centric

Putting Patients First to Improve Lives Through Innovation